AXOSIM PARTNERS WITH PRECLINICAL SCIENTISTS TO SOLVE ADVANCED PROBLEMS IN THE DRUG DISCOVERY AND DEVELOPMENT PROCESSES
Selection of drug candidates is a difficult and imperfect process requiring predictive modeling. Too often, animal and other preclinical models are not predictive in humans. Without this knowledge, selection of the wrong candidate can result in losses of money, time, and resources. We aim to help navigate this path by providing rodent and human predictive in vitro modeling.
Our industry leading biomimetic platforms enable us to work with our clients and partners to apply predictive data assisting in identification of better drug candidates, earlier, and more accurately and efficiently.
1) Drug Discovery: Shortening the time to lead candidate selection with human targets in phenotypic assays.
2) Preclinical: Broadening the preclinical funnel while shortening the time to clinical candidate selection.
3) Clinical: Accelerating IND filing with improved translation a success.